Because they are a strange hybrid between smoking which kills nearly 6 million people a year and stop-smoking medications, e-cigs rival both
tobacco and pharma.
tobacco companies have responded to that
threat by buying up e-cig businesses, and are now funding research.
Pharma firms have kept their distance.